Doccla's £35M Leap: A New Era in Remote Patient Care
September 4, 2024, 10:45 am
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Founded date: 2000
In the fast-paced world of healthcare, innovation is the lifeblood. Doccla, a London-based company, has just secured £35 million in a Series B funding round. This significant investment is not just a financial boost; it’s a catalyst for change in how we approach patient care.
Doccla specializes in virtual ward and remote patient monitoring services. Think of it as a bridge connecting patients to healthcare providers, ensuring that care doesn’t stop at the hospital door. With this new funding, Doccla aims to expand its reach across Europe, particularly targeting France and the DACH region—Germany, Austria, and Switzerland.
The round was led by Lakestar, a venture capital firm known for backing transformative tech companies. They were joined by Elaia and existing investors like General Catalyst, Bertelsmann Investments, and Speedinvest. The backing from these firms signals confidence in Doccla’s vision and potential. Oliver Heimes from Lakestar will join the Doccla board, bringing fresh insights and strategic direction.
Doccla’s mission is clear: to provide hospital-level care at home. This approach is revolutionary. It allows patients to recover in the comfort of their homes while still receiving top-notch medical attention. The technology behind Doccla enables 24/7 monitoring across 40 different pathways. Medical staff can access real-time patient data, identifying potential issues before they escalate. This proactive strategy not only reduces emergency admissions but also eases the burden on healthcare systems.
The roots of Doccla run deep. Founded by Martin Ratz and Dag Larsson, the company emerged from a personal experience. Ratz’s unexpected heart attack opened his eyes to the gaps in post-hospital care. He realized that many patients struggle when transitioning from hospital to home. With a background in health tech, he and Larsson set out to fill this void.
Doccla’s services have already made waves in the UK. They work with NHS Trusts across more than half of the NHS regions, monitoring patients in over 10 European countries. Recently, they partnered with Ireland’s Health Service Executive (HSE), further solidifying their presence in the region. The company has recorded millions of monitored patient days, showcasing the effectiveness of their model.
The funding will not only help Doccla solidify its position in the UK and Ireland but also pave the way for international growth. The European healthcare landscape is ripe for innovation. With an aging population and increasing demand for healthcare services, remote patient monitoring is becoming essential. Doccla is poised to lead this charge.
The technology behind Doccla is impressive. Their virtual wards leverage connected medical devices to monitor patients’ vital signs from home. This setup allows healthcare providers to keep a close eye on patients without the need for constant hospital visits. It’s a win-win situation: patients enjoy the comfort of home, while healthcare systems can allocate resources more efficiently.
The healthcare market is crowded, with various players offering remote monitoring solutions. Companies like Honeywell Lifecare and Medtronic are also in the game, but Doccla’s unique approach sets it apart. By focusing on a seamless transition from hospital to home, Doccla addresses a critical pain point in patient care.
As Doccla expands, it will likely face challenges. Entering new markets requires understanding local regulations, patient needs, and healthcare systems. However, the company’s track record suggests it is up to the task. With a solid foundation in the UK and a growing presence in Europe, Doccla is ready to take on the world.
The potential for growth is immense. The global remote patient monitoring market is projected to soar in the coming years. As healthcare continues to evolve, the demand for innovative solutions will only increase. Doccla is not just riding the wave; it’s helping to shape the future of healthcare.
Investors are taking notice. The recent funding round was oversubscribed, indicating strong interest in Doccla’s vision. The backing from reputable firms like Lakestar and General Catalyst speaks volumes about the company’s potential. With their support, Doccla can accelerate its growth and enhance its offerings.
The healthcare landscape is changing. Patients are no longer passive recipients of care; they are active participants in their health journeys. Doccla empowers patients by providing them with the tools and support they need to manage their health from home. This shift is not just beneficial for patients; it also alleviates pressure on healthcare systems.
In conclusion, Doccla’s £35 million funding is more than just a financial milestone. It represents a significant step toward a future where healthcare is more accessible, efficient, and patient-centered. As the company expands its reach across Europe and beyond, it will undoubtedly continue to innovate and redefine what it means to receive care. The journey has just begun, and the horizon is bright.
Doccla specializes in virtual ward and remote patient monitoring services. Think of it as a bridge connecting patients to healthcare providers, ensuring that care doesn’t stop at the hospital door. With this new funding, Doccla aims to expand its reach across Europe, particularly targeting France and the DACH region—Germany, Austria, and Switzerland.
The round was led by Lakestar, a venture capital firm known for backing transformative tech companies. They were joined by Elaia and existing investors like General Catalyst, Bertelsmann Investments, and Speedinvest. The backing from these firms signals confidence in Doccla’s vision and potential. Oliver Heimes from Lakestar will join the Doccla board, bringing fresh insights and strategic direction.
Doccla’s mission is clear: to provide hospital-level care at home. This approach is revolutionary. It allows patients to recover in the comfort of their homes while still receiving top-notch medical attention. The technology behind Doccla enables 24/7 monitoring across 40 different pathways. Medical staff can access real-time patient data, identifying potential issues before they escalate. This proactive strategy not only reduces emergency admissions but also eases the burden on healthcare systems.
The roots of Doccla run deep. Founded by Martin Ratz and Dag Larsson, the company emerged from a personal experience. Ratz’s unexpected heart attack opened his eyes to the gaps in post-hospital care. He realized that many patients struggle when transitioning from hospital to home. With a background in health tech, he and Larsson set out to fill this void.
Doccla’s services have already made waves in the UK. They work with NHS Trusts across more than half of the NHS regions, monitoring patients in over 10 European countries. Recently, they partnered with Ireland’s Health Service Executive (HSE), further solidifying their presence in the region. The company has recorded millions of monitored patient days, showcasing the effectiveness of their model.
The funding will not only help Doccla solidify its position in the UK and Ireland but also pave the way for international growth. The European healthcare landscape is ripe for innovation. With an aging population and increasing demand for healthcare services, remote patient monitoring is becoming essential. Doccla is poised to lead this charge.
The technology behind Doccla is impressive. Their virtual wards leverage connected medical devices to monitor patients’ vital signs from home. This setup allows healthcare providers to keep a close eye on patients without the need for constant hospital visits. It’s a win-win situation: patients enjoy the comfort of home, while healthcare systems can allocate resources more efficiently.
The healthcare market is crowded, with various players offering remote monitoring solutions. Companies like Honeywell Lifecare and Medtronic are also in the game, but Doccla’s unique approach sets it apart. By focusing on a seamless transition from hospital to home, Doccla addresses a critical pain point in patient care.
As Doccla expands, it will likely face challenges. Entering new markets requires understanding local regulations, patient needs, and healthcare systems. However, the company’s track record suggests it is up to the task. With a solid foundation in the UK and a growing presence in Europe, Doccla is ready to take on the world.
The potential for growth is immense. The global remote patient monitoring market is projected to soar in the coming years. As healthcare continues to evolve, the demand for innovative solutions will only increase. Doccla is not just riding the wave; it’s helping to shape the future of healthcare.
Investors are taking notice. The recent funding round was oversubscribed, indicating strong interest in Doccla’s vision. The backing from reputable firms like Lakestar and General Catalyst speaks volumes about the company’s potential. With their support, Doccla can accelerate its growth and enhance its offerings.
The healthcare landscape is changing. Patients are no longer passive recipients of care; they are active participants in their health journeys. Doccla empowers patients by providing them with the tools and support they need to manage their health from home. This shift is not just beneficial for patients; it also alleviates pressure on healthcare systems.
In conclusion, Doccla’s £35 million funding is more than just a financial milestone. It represents a significant step toward a future where healthcare is more accessible, efficient, and patient-centered. As the company expands its reach across Europe and beyond, it will undoubtedly continue to innovate and redefine what it means to receive care. The journey has just begun, and the horizon is bright.